<VariationArchive VariationID="3246600" VariationName="NC_000004.11:g.(?_178352862)_(178360031_?)del" VariationType="Deletion" Accession="VCV003246600" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3402742" VariationID="3246600">
      <GeneList>
        <Gene Symbol="AGA" FullName="aspartylglucosaminidase" GeneID="175" HGNC_ID="HGNC:318" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="177430774" stop="177442437" display_start="177430774" display_stop="177442437" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="178351927" stop="178363656" display_start="178351927" display_stop="178363656" Strand="-" />
          </Location>
          <OMIM>613228</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000004.11:g.(?_178352862)_(178360031_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" innerStart="178352862" innerStop="178360031" display_start="178352862" display_stop="178360031" variantLength="7170" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.(?_178352862)_(178360031_?)del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.(?_178352862)_(178360031_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000004.11:g.(?_178352862)_(178360031_?)del AND Aspartylglucosaminuria" Accession="RCV004580705" Version="1">
        <ClassifiedConditionList TraitSetID="72">
          <ClassifiedCondition DB="MedGen" ID="C0268225">Aspartylglucosaminuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11309371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1904874</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2011603</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21228398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7627186</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="72" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="551" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aspartylglucosaminuria</ElementValue>
                <XRef ID="HP:0012068" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008830" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOASPARAGINASE</ElementValue>
                <XRef Type="MIM" ID="208400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aspartylglycosaminuria</ElementValue>
                <XRef ID="Aspartylglucosaminuria/622" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aspartylglucos-aminuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aspartylglucos-amidase (AGA) deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycosylasparaginase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AGU</ElementValue>
                <XRef Type="MIM" ID="208400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5854" />
                <XRef ID="5854" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">38252773</ID>
                <ID Source="BookShelf">NBK599378</ID>
              </Citation>
              <XRef ID="93" DB="Orphanet" />
              <XRef ID="C0268225" DB="MedGen" />
              <XRef ID="MONDO:0008830" DB="MONDO" />
              <XRef Type="MIM" ID="208400" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012068" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9837134" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000004.11:g.(?_178352862)_(178360031_?)del|MedGen:C0268225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005064729" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1703489</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1904874</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2011603</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7627186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11309371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21228398</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 4-9 of the AGA gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with AGA-related conditions. This variant disrupts a region of the AGA protein in which other variant(s) (p.Cys163Ser) have been determined to be pathogenic (PMID: 1703489, 1904874, 2011603, 7627186, 11309371, 21228398). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.(?_178352862)_(178360031_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268225" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9837134" TraitType="Disease" MappingType="XRef" MappingValue="C0268225" MappingRef="MedGen">
        <MedGen CUI="C0268225" Name="Aspartylglucosaminuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

